MARKET

SCLXW

SCLXW

Scilex Holding Company
NASDAQ
0.1359
-0.0119
-8.02%
Closed 15:42 06/09 EDT
OPEN
0.1359
PREV CLOSE
0.1478
HIGH
0.1359
LOW
0.1359
VOLUME
1.51K
TURNOVER
--
52 WEEK HIGH
0.6500
52 WEEK LOW
0.0501
MARKET CAP
--
P/E (TTM)
-0.0034
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SCLX last week (0601-0605)?
Weekly Report · 1d ago
Press Release: Scilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
Dow Jones · 5d ago
Weekly Report: what happened at SCLX last week (0525-0529)?
Weekly Report · 06/01 09:48
Top Biotech Gainers: REPL On Track, SNSE Awaits Phase 2 Data, Keep An Eye On CCCC, IMRX Soars
NASDAQ · 06/01 02:29
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 05/29 17:06
Weekly Report: what happened at SCLX last week (0518-0522)?
Weekly Report · 05/25 09:50
Scilex Approves Dividend Distribution Of ~10.7M Semnur Pharmaceuticals Common Stock To Eligible Scilex Stockholders And Equityholders On A 1-For-1 Basis
Benzinga · 05/22 17:32
Scilex approves dividend of Semnur Pharmaceuticals shares
TipRanks · 05/22 17:26
More
About SCLXW
Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. Its second commercial product ELYXYB, is a potential first-line treatment, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. Its product candidates include SP-102 (SEMDEXA), SP-103 and SP-104. SP-102 is a viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica. Its SP-103 is a triple-strength formulation of ZTlido, for the treatment of chronic neck pain.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLXW stock methods without spending real money on the virtual paper trading platform.